Phase 2 Dose-finding, Double-blind Controlled Study of SFPP in Knee Osteoarthritis 2nd
Phase 2
- Conditions
- Osteoarthritis of the knee
- Registration Number
- JPRN-jRCT2080220876
- Lead Sponsor
- Taisho Pharmaceutical co., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Outpatient able to walk
- Patients who agreed to X-ray diagnosis criteria: Kellegren-Lawrence grade 2-3.
etc.
Exclusion Criteria
- Patients who underwent surgery (including arthroscopy) in their knees.
- Patients with comorbid serious hepatic, renal, cardiac, or hematologic disease or malignancy
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method